Skip to content

Meet the local startup that wants to be the Spotify for medical professionals

When I spoke to Mike Donoghue, CEO and co-founder of Convey Pro Inc., I noted that I had numerous friends in medical school and residency — which, as it happens, are also set to be the target audience for his company.

“It’s funny you say that, because that’s the sweet spot demographic,” he said. “That’s part of the thesis of our business model, that young professionals particularly would crave this kind of content, delivered this way.”

He refers to medical podcasts, a niche type of content that the company curates on its app, ConveyMD. The platform launched recently, and the goal, explained Donoghue, a former Smith & Nephew marketing exec, is to be “the Spotify for medical professionals.”

Currently, it has about 100 podcasts on the app, and much of the content is free, as many of the podcasts are available on major media platforms. Yet through partnerships with continuing medical education (CME) providers, like the Orthopaedic Trauma Association and American Orthopaedic Foot and Ankle Society, ConveyMD will also provide exclusive, accredited content for purchase — and this, Donoghue believes, is what sets it apart.


Johnson & Johnson’s COVID-19 Vaccine: Detroit Mayor Declines 6,200 Doses, Catholic Bishops Raise ‘Moral Concerns’

The rollout of the Johnson & Johnson (NYSE: JNJ) COVID-19 vaccine hit a pair of potholes this week as the mayor of Detroit said the city was sticking with Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) vaccines for now, highlighting Johnson & Johnson’s lower efficacy rate, before walking back his comments. And the nation’s Catholic bishops questioned the Johnson & Johnson vaccine’s morality because it was created from cell lines derived from an aborted human fetus.


Dr. Scott Gottlieb sees promising signs that Covid vaccines reduce virus transmission

Dr. Scott Gottlieb said Monday he sees promising signs that suggest Covid vaccines are effective in reducing person-to-person spread of the virus in addition to their well-documented ability to protect against severe disease. In an interview on CNBC’s “Squawk Box,” the former Food and Drug Administration commissioner cautioned that while the early data appears positive, some uncertainty remains. “I think there’s a reduction in transmission. The question is: What’s the magnitude of that?” said Gottlieb, a member of Pfizer’s board of directors.


Johnson & Johnson’s one-shot COVID vaccine authorized for emergency use

https://www.cbsnews.com/news/covid-vaccine-johnson-and-johnson-authorized-emergency-use/

The Food and Drug Administration on Saturday authorized Johnson & Johnson’s COVID-19 vaccine for emergency use. The vaccine is the third to be approved for use in the United States, and the first that requires only one shot. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend authorizing the vaccine by Janssen, a division of Johnson & Johnson, on Friday. The committee provides expert advice to the FDA but does not have final say on approval. “The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States,” said Acting FDA Commissioner Dr. Janet Woodcock on Saturday. 


Johnson & Johnson COVID vaccine: What you need to know with the single-dose vaccine set to reach Maryland

The U.S. Food and Drug Administration is expected to grant emergency use authorization to Johnson & Johnson’s single-dose COVID-19 vaccine this week, a move that would ease the nationwide supply constraints and bring America one step closer to combating the coronavirus pandemic. Data suggests the vaccine, made by Johnson & Johnson’s Janssen Pharmaceutical Companies, is safe and effective, especially at preventing severe disease, scientists and medical experts say.


Pfizer-BioNTech Shot Stops Covid Spread, Israeli Study Shows

The Pfizer Inc. and BioNTech SE Covid-19 vaccine appeared to stop the vast majority of recipients in Israel becoming infected, providing the first real-world indication that the immunization will curb transmission of the coronavirus. The vaccine, which is being rolled out in a national immunization program that began Dec. 20, was 89.4% effective at preventing laboratory-confirmed infections, according to a copy of a draft publication that was posted on Twitter and confirmed by a person familiar with the work. The companies worked with Israel’s Health Ministry on the preliminary observational analysis, which wasn’t peer-reviewed. Some scientists disputed its accuracy.


2020 editors’ choice articles

Before we hit the ground running with new topics for 2021, we want to say thank you to our authors, readers and advertisers. It has been an amazing experience seeing the marketing research and insight community come together and find innovative ways to collect data and use it for good. Here, you will find a selection of our editors’ favorite articles from the last year. Trust us  it was hard to narrow our lists down to just these few! From blogs sharing career advice for those struggling during the pandemic, to magazine and e-newsletter articles discussing COVID-19’s impact on marginalized consumers, we’ve received so many quality submissions that we were proud to publish in 2020. 


23 Top Panel Research Companies

When seeking respondents for research, companies can benefit from panels through their ability to provide quick and easy access to respondents, even those who belong to niche audiences. Panels also ensure a dedicated group of respondents for your research, decreasing instances of fraud or unengaged responses. 

The following companies offer a wide range of panels featuring respondents from niche and broad audiences – from health care specialists and administrators to B2B decision makers to IT – and offering services in numerous countries and languages. If your research needs require the specificity and accessibility of panels, these companies are here to help.


Successful strategies for B2B research and fraud mitigation

By: Molly Strawn, Senior Marketing Strategist, InnovateMR

Throughout the market research and survey fielding process, it is essential to keep in mind respondent data quality from start to finish. This year, Cybersecurity Ventures anticipates $6 trillion in damages as fraud methodologies have become more advanced and more sophisticated. Acknowledging that these dangers exist is vital to position research for success. To tackle this challenge, Lisa Wilding-Brown from InnovateMR, Hilary DeCamp from the LRW Group and John Voda from AT&T joined forces to educate the industry about top data quality methodologies. Their holistic insights cover design, sampling and data analysis.


Business to business: A human-to-human approach for creative connection

By: Yogesh Shah, CEO, iResearch Services

It’s The need for agility and innovation across all areas of the business, led by senior management, means that everyone needs to be aligned to the customer’s needs and wants and be shaping strategic direction around them. It’s not enough for marketing, sales or specific individuals to be the only ones in the know about existing and potential customers – that knowledge, understanding and insight needs to come from the top. not as simple as just B2B and B2C anymore. Digital transformation and COVID-19 have changed the way people live and work – and this needs to be recognized in the way companies communicate with and engage clients and potential customers. Especially in times of uncertainty, the ability to see people as human beings and reflect that in insight and interaction is crucial.

Designed using Nevark. Powered by WordPress.